The global antibody fragments market size is estimated to be USD 17.89 billion in 2021 and is expected to witness a CAGR of 8.5% during the forecast period. Increasing incidence of target diseases is a key driver for the growth of the global antibody fragments market. Additionally, benefits over full length antibodies and rise in encouraging initiatives taken by government are some of the other drivers propelling the market growth. Nevertheless, stringent regulatory procedures, lack of knowledge regarding antibody fragments among developing economies and hindrance in manufacturing and sanitization of antibody fragments are expected to restrain the global market growth.

By Type

Based on type, the market is segmented into F(ab’)2 fragments and F(ab) fragments. In 2021, the F(ab) fragments segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This can be attributed to the segment being applied to block the endogenous Ig’s-immunoglobulins worldwide. F(ab’)2 fragments segment is projected to grow at a profitable CAGR during the forecast period. This can be attributed to the rise in application of this segment as they offer improved antigen recognition feature, as these antibody fragments evade any undefined binding.

By Application

Based on application segment, the market is sub segmented into cancer, immunodeficiencies, and other applications. In 2021, the cancer segment accounted for the substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This can be attributed to the rise in incidence of cancer along with the fact that maximum of the antibody fragments presently undergoing clinical trials are directed towards cancer and related diseases worldwide. Immunodeficiencies segment is projected to grow at a profitable CAGR during the forecast period. This is attributed to the growing investment in R&D activities for new product development along with the introduction of new products in the emerging market.

Regional Insights

In 2021, North America region accounted for the highest revenue share in the global market and is estimated to continue its dominance during the forecast period. This is attributed to the rise in prevalence of target diseases, presence of major players in the region, positive reimbursement scenario, and growth in initiatives from the government, accessibility of technologically advanced products in the region. Asia Pacific market is projected to grow at the fastest CAGR over the forecast period owing to less stringent regulations, growing government and corporate investment in healthcare sector, increasing travel tourism in developing economies, and growth in the share of healthcare expenditure in the per capita income.

Competitor Insights

Some of the key players in the antibody fragments market are F. Hoffmann-La Roche AG (Switzerland); Johnson & Johnson (U.S.); Amgen Inc. (U.S.); Bristol-Myers Squibb (U.S.); AbbVie (U.S.); The Takeda Pharmaceutical Company Limited (Japan); Sanofi S.A. (France); Biogen Inc. (U.S.); Eli Lilly and Company (U.S.); and Albynx (Belgium). The leading players operating in the antibody fragments industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The antibody fragments market report is categorized into the following segments and subsegments:

Antibody Fragments Market, By Type (Revenue, USD Billion, 2021 – 2029)

Antibody Fragments Market, By Application (Revenue, USD Billion, 2021 – 2029)

Antibody Fragments Market, By Region (Revenue, USD Billion, 2021 – 2029)

Scope of Antibody Fragments Market Report:

Key Parameters	Details
Base Year	2021
Forecast Period	2022-2029
Study Coverage	Global and regional market size and revenue forecast Segment market size and revenue forecast at global, regional, and country level Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis) Conclusion and recommendations
Qualitative Analysis	Market drivers Market restraints Market opportunities Recent market trends Market challenges Porter’s Five Forces analysis PEST analysis Value-chain analysis COVID-19 impact analysis
Regional Market Scope	North America (U.S. and Canada) Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC) Latin America (Brazil, Mexico, Argentina, Rest of LATAM) MEA (South Africa, GCC, Rest of MEA)
Company Profiles	Exhaustive profiles of top 15 players 50+ other major players listing
15% Free Customization Available	You can customize the study scope to meet your exact requirement. Click here for more details